 Connor Clark Lunn Investment Management Ltd. bought a new position in shares of Eiger Biopharmaceuticals Inc NASDAQ:EIGR during the fourth quarter, according to its most recent disclosure with the Securities Exchange Commission. The fund bought 14,375 shares of the biotechnology companys stock, valued at approximately 214,000. Connor Clark Lunn Investment Management Ltd. ... 